Department of Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
Am J Phys Med Rehabil. 2013 Mar;92(3):223-31. doi: 10.1097/PHM.0b013e31826edd97.
The aim of this study was to identify commonly reported symptoms in the lower limbs among those with or at risk for developing lower limb lymphedema (LLL).
The authors surveyed survivors of long-term cancer using the Pennsylvania State Cancer Registry. They inquired about demographics, cancer treatment history, knowledge about LLL, and symptoms experienced since completing cancer treatment. They invited all participants for an in-person clinical assessment to better identify and characterize the symptoms associated with LLL.
The response rate to the study survey was 57.2%. Among the 107 participants who answered the study survey, 37 (34.5%) reported one or more symptoms associated with LLL. Many reported a combination of symptoms that included difficulty walking (n = 37; 100%), aching (n = 32; 86%), puffiness (n = 28; 76%), and pain (n = 27; 73%) on one side of the body since cancer treatment. The in-person clinical assessment among a subsample of 17 participants revealed 10 participants with no evidence of LLL and 5 and 2 participants with grade 1 and 2 LLL, respectively. The in-person clinical assessment identified three cases of previously undiagnosed LLL.
One third of the survivors of cancer surveyed reported experiencing new symptoms in the lower limbs since cancer treatment. Cases of symptomatic, undiagnosed LLL may exist in the population.
本研究旨在识别下肢淋巴水肿(LLL)患者或有发生 LLL 风险者下肢常见报告症状。
作者使用宾夕法尼亚州癌症登记处对长期癌症幸存者进行了调查。他们询问了参与者的人口统计学资料、癌症治疗史、对 LLL 的了解以及癌症治疗结束后出现的症状。他们邀请所有参与者进行面对面的临床评估,以更好地识别和描述与 LLL 相关的症状。
对研究调查的回复率为 57.2%。在回答研究调查的 107 名参与者中,有 37 名(34.5%)报告了一种或多种与 LLL 相关的症状。许多人报告了多种症状,包括癌症治疗后单侧行走困难(n=37;100%)、酸痛(n=32;86%)、肿胀(n=28;76%)和疼痛(n=27;73%)。在 17 名参与者的亚样本中进行了面对面的临床评估,发现 10 名参与者没有 LLL 证据,5 名和 2 名参与者分别有 1 级和 2 级 LLL。面对面的临床评估发现了 3 例以前未确诊的 LLL。
接受调查的癌症幸存者中有三分之一报告称癌症治疗后下肢出现新症状。可能存在有症状但尚未确诊的 LLL 病例。